[This corrects the article DOI: 10.3389/fphar.2019.01287.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10950444 | PMC |
| http://dx.doi.org/10.3389/fphar.2024.1334971 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Increasing the antitumor efficacy of doxorubicin liposomes with coupling an anti-EGFR affibody in EGFR-expressing tumor models" [Int. J. Pharm. 586 (2020) 119541].
Int J Pharm
January 2025
Laboratory of Drug Discovery and Design, School of Pharmacy, Liaocheng University, Liaocheng, Shandong 252000, PR China. Electronic address:
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells.
Front Oncol
December 2024
Department of Medicine and Surgery, University of Parma, Parma, Italy.
[This corrects the article DOI: 10.3389/fonc.2022.
View Article and Find Full Text PDFCorrigendum to "Combination of MAPK inhibition with photothermal therapy synergistically augments the anti-tumor efficacy of immune checkpoint blockade" [Journal of Controlled Release 332 (2021) 194-209].
J Control Release
January 2025
Laboratory of Tumor Targeted and Immune Therapy, Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041 Chengdu, Sichuan, China. Electronic address:
Corrigendum: Dietary polyphenols, resveratrol and pterostilbene exhibit antitumor activity on an HPV E6-positive cervical cancer model: an and analysis.
Front Oncol
October 2024
Doctoral Program in Biology, CUNY Graduate Center, New York, NY, United States.
[This corrects the article DOI: 10.3389/fonc.2019.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!